The role of the Bcl-2 protein family in cancer
- 18 March 2003
- journal article
- review article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 13 (2) , 115-123
- https://doi.org/10.1016/s1044-579x(02)00129-3
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Anoikis mechanismsCurrent Opinion in Cell Biology, 2001
- The activity of the murine Bax promoter is regulated by Sp1/3 and E-box binding proteins but not by p53Cell Death & Differentiation, 1999
- Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic miceOncogene, 1997
- Structure of Bcl-x L -Bak Peptide Complex: Recognition Between Regulators of ApoptosisScience, 1997
- Programmed Cell Death in Animal DevelopmentCell, 1997
- Mutations in Fas Associated with Human Lymphoproliferative Syndrome and AutoimmunityScience, 1995
- Activation of C. elegans cell death protein CED-9 by an ammo-acid substitution in a domain conserved in Bcl-2Nature, 1994
- Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosisNature, 1992
- bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytesCell, 1991
- The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic miceNature, 1985